Status:
UNKNOWN
Serum Level of IL31,33 and 36 in Egyptian Paients With Psoriasis
Lead Sponsor:
Assiut University
Conditions:
Psoriasis
Eligibility:
All Genders
Brief Summary
Evaluating Serum Level Of IL 31 , IL33 and IL36 and Their Correlation with Disease Activity In Patients With Psoriasis In Assuit University Hospital . * To correlate their levels with disease activit...
Detailed Description
Serum samples will be collected from 45 psoriasis patients and 45 matched healthy individuals. After full history taking and dermatological examination, the disease severity will be assessed using the...
Eligibility Criteria
Inclusion
- Patients with all types of psoriasis.
- healthy volunteers without a family history of psoriasis or other autoimmune disease.
Exclusion
- other autoimmune , other chronic inflammatory or systemic diseases.
- cases received glucocorticoids, immunosuppressive drugs at least 1 month before sample collection .
Key Trial Info
Start Date :
June 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
July 1 2021
Estimated Enrollment :
90 Patients enrolled
Trial Details
Trial ID
NCT04344574
Start Date
June 1 2020
End Date
July 1 2021
Last Update
April 14 2020
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.